Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

No evidence for CCVSI in relapsing-remitting multiple sclerosis patients with moderate disability.
Multiple sclerosis: Effect of smoking on antibody response to IFN-β treatment.
Multiple sclerosis severity score in a cohort of Moroccan patients.
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Second generation S1P pathway modulators: Research strategies and clinical developments.
Do Bugs Control Our Fate? The Influence of the Microbiome on Autoimmunity.
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?
Patients' perspectives on quality of mental health care for people with MS.
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.
Neuroimmunological diseases and pregnancy.
Factors for lower walking speed in persons with multiple sclerosis.
LIVER X RECEPTORS, NERVOUS SYSTEM AND LIPID METABOLISM.
Platelets and autoimmunity.
Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.
Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.
CRYAB modulates the activation of CD4+ T cells from relapsing-remitting multiple sclerosis patients.
Impaired adult myelination in the prefrontal cortex of socially isolated mice.
Interview: Experiences targeting B cells for the treatment of multiple sclerosis.
Polypharmacy in multiple sclerosis: Relationship with fatigue, perceived cognition, and objective cognitive performance.
A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort.
To be 17 again--anti-interleukin-17 treatment for psoriasis.
Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D.
A Patient Care Program for Adjusting the Autoinjector Needle Depth According to Subcutaneous Tissue Thickness in Patients With Multiple Sclerosis Receiving Subcutaneous Injections of Glatiramer Acetate.
Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease.
Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.

Pages